Summary
This filing is an amendment (8-K/A) to a previous 8-K report filed by IDEXX LABORATORIES INC /DE (IDXX) on July 17, 2017. The original report disclosed the appointment of Dr. Stuart M. Essig to the company's Board of Directors. This amendment primarily serves to provide updated information regarding Dr. Essig's committee assignments, which were not finalized at the time of the original filing.
Key Highlights
- 1Amendment to a previous 8-K filing regarding board appointments.
- 2Provides updated information on committee assignments for newly appointed director Dr. Stuart M. Essig.
- 3Dr. Essig has been appointed to the Compensation Committee and the Nominating and Governance Committee of the Board.
- 4These committee assignments were effective as of October 18, 2017.
- 5The company confirmed that Dr. Essig meets all requirements to serve on these committees.
- 6No other disclosures from the original filing are being amended.
- 7The filing was made on October 22, 2017, with an event date of July 11, 2017.
Frequently Asked Questions
The main purpose of this 8-K/A filing is to amend a previous 8-K report to provide updated information on the committee assignments of Dr. Stuart M. Essig, who was recently appointed to the Board of Directors.
Dr. Stuart M. Essig has been appointed to the Compensation Committee and the Nominating and Governance Committee of IDEXX LABORATORIES INC /DE's Board of Directors.
The committee appointments for Dr. Essig were effective immediately as of October 18, 2017.
No, other than providing the additional information on committee assignments in Item 5.02, no other disclosures in the original 8-K filing are amended by this Form 8-K/A.